4FAL
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihydroisoquinolin-2(1H)-yl)sulfonyl)-N-methylbenzamide (80)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2010-04-20 |
Detector | RIGAKU SATURN 944+ |
Wavelength(s) | 1.54182 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 58.687, 64.703, 96.650 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 18.650 - 2.000 |
R-factor | 0.18361 |
Rwork | 0.182 |
R-free | 0.22129 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2fgb |
RMSD bond length | 0.023 |
RMSD bond angle | 1.915 |
Phasing software | PHASER |
Refinement software | REFMAC (5.5.0072) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 18.650 | 2.070 |
High resolution limit [Å] | 2.000 | 2.000 |
Number of reflections | 24949 | |
Completeness [%] | 97.9 | 95.2 |
Redundancy | 3.5 | 2.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8 | 289 | 25 % (w/v) PEG1500, 0.1M PCTP buffer, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 289K |